INADL expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.9077408803555E-12 |
Normal-vs-Stage2 |
1.92125999999293E-05 |
Normal-vs-Stage3 |
1.77635683940025E-15 |
Normal-vs-Stage4 |
1.62458935193399E-12 |
Stage1-vs-Stage2 |
9.344600E-01 |
Stage1-vs-Stage3 |
5.997200E-03 |
Stage1-vs-Stage4 |
1.33570000004912E-06 |
Stage2-vs-Stage3 |
7.850000E-02 |
Stage2-vs-Stage4 |
2.839300E-03 |
Stage3-vs-Stage4 |
6.455900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62458935193399E-12 |
Normal-vs-AfricanAmerican |
1.03830000153238E-09 |
Normal-vs-Asian |
5.690800E-01 |
Caucasian-vs-AfricanAmerican |
5.815000E-01 |
Caucasian-vs-Asian |
6.468000E-02 |
AfricanAmerican-vs-Asian |
3.113800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
2.16899999960773E-07 |
Male-vs-Female |
2.10079999951596E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.93973742518483E-12 |
Normal-vs-Age(41-60Yrs) |
1.13686837721616E-13 |
Normal-vs-Age(61-80Yrs) |
1.62481139653892E-12 |
Normal-vs-Age(81-100Yrs) |
6.281500E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.716800E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.983500E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.006200E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.197400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.796400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.856000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.162000E-01 |
Normal-vs-Grade 2 |
8.15979506185727E-11 |
Normal-vs-Grade 3 |
1.62525548574877E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
3.919700E-02 |
Grade 1-vs-Grade 3 |
3.002800E-03 |
Grade 1-vs-Grade 4 |
1.798900E-04 |
Grade 2-vs-Grade 3 |
1.664200E-02 |
Grade 2-vs-Grade 4 |
1.65700786425305E-12 |
Grade 3-vs-Grade 4 |
2.95969999619672E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.60530000000004E-05 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
1.62436730732907E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.64734892393881E-12 |
Normal-vs-N1 |
3.76999986784199E-10 |
N0-vs-N1 |
4.356400E-02 |
|
|